文献速递生殖医学

细胞因子用于人胚胎体外培养展现前景:一项随机临床试验结果

Cytokines hold promise for human embryo culture in vitro: results of a randomized clinical trial.
PubMed 文献 · Fertil Steril · 2019-09-21

该随机临床试验纳入443个ICSI周期,评估在培养液中添加粒细胞-巨噬细胞集落刺激因子、肝素结合表皮生长因子样生长因子和白血病抑制因子对胚胎发育及临床结局的影响。细胞因子添加组持续妊娠率、活产率、累积活产率均高于常规培养液组,流产率更低,囊胚形成、质量、冷冻保存及可用率更优;但长期影响尚不明确,需纵向随访进一步研究。

要点

  • 细胞因子添加组持续妊娠率47%(106/224)vs 对照组36%(78/219),绝对率差12(95%CI 2.5-21)。
  • 细胞因子添加组活产率45%(101/224)vs 对照组33%(71/219),绝对率差13(95%CI 4-21)。
  • 细胞因子添加组流产率22%(27/124)vs 对照组36%(37/103),绝对率差-14(95%CI -26至-2)。

核心结论

  • 在人胚胎培养液中添加细胞因子可改善ICSI后的胚胎学与临床结局。
  • 细胞因子添加培养液的长期效应仍不明确,需纵向随访进一步研究。

研究设计与样本

  • 随机临床试验,在体外受精中心进行,共纳入443个ICSI周期并随机分为两组。
  • 干预为在培养液中添加粒细胞-巨噬细胞集落刺激因子、肝素结合表皮生长因子样生长因子和白血病抑制因子,对照为常规培养液。
  • 主要结局指标为每个随机参与者的持续妊娠率。

主要发现

  • 细胞因子添加组持续妊娠率47%(106/224)vs 对照组36%(78/219),绝对率差12(95%CI 2.5-21)。
  • 细胞因子添加组活产率45%(101/224)vs 对照组33%(71/219),绝对率差13(95%CI 4-21)。
  • 细胞因子添加组累积活产率60%(132/224)vs 对照组44%(97/219),绝对率差12(95%CI 4-20)。
  • 细胞因子添加组流产率22%(27/124)vs 对照组36%(37/103),绝对率差-14(95%CI -26至-2)。
  • 细胞因子添加培养液中发育的胚胎在囊胚形成、质量、冷冻保存及使用方面优于对照培养液。

局限性

  • 细胞因子添加培养液的长期效应仍不明确,需纵向随访进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effects of cytokine enrichment of culture medium on embryological and clinical outcomes after intracytoplasmic sperm injection (ICSI). DESIGN: A randomized clinical trial. SETTING: In vitro fertilization centers. PATIENT(S): This trial included 443 ICSI cycles randomized into two groups. INTERVENTION(S): This study evaluated the influence of integration of granulocyte-macrophage colony-stimulating factor, heparin-binding epidermal growth factor-like growth factor, and leukemia inhibitory factor into culture media on human embryo development after ICSI. MAIN OUTCOME MEASURE(S): Ongoing pregnancy rate per a randomized participant. RESULT(S): Cytokine enrichment of culture medium showed improvement in ongoing pregnancy rate compared with no cytokines (106/224 [47%] vs. 78/219 [36%]; absolute rate difference [ARD] = 12; 95% confidence interval [CI], 2.5-21). This integration of cytokines also showed better rates of live birth (101/224 [45%] vs. 71/219 [33%]; ARD = 13; 95% CI, 4-21) and cumulative live birth (132/224 [60%] vs. 97/219 [44%]; ARD = 12; 95% CI, 4-20) and lower rate of pregnancy loss (27/124 [22%] vs. 37/103 [36%]; ARD = -14; 95% CI, -26 to -2) than conventional medium. Embryos developed in the cytokine-supplemented medium showed better blastocyst formation, quality, cryopreservation, and use than control medium. CONCLUSION(S): Integration of cytokines into human embryo culture media showed improvement in embryological and clinical outcomes after ICSI. However, the long-term effect of cytokine enrichment of a medium is still unclear and warrants further studies with longitudinal follow-up. CLINICAL TRIAL REGISTRATION NUMBER: NCT02420886 at ClinicalTrials.gov.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Fawzy M, Emad M, Elsuity MA, et al. Cytokines hold promise for human embryo culture in vitro: results of a randomized clinical trial. Fertil Steril. 2019. PMID: 31551154. doi:10.1016/j.fertnstert.2019.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。